ACCURACY IS NOT OPTIONAL

Serial Number 97442210
794

Registration Progress

Application Filed
Jun 3, 2022
Under Examination
Approved for Publication
Apr 25, 2023
Published for Opposition
Apr 25, 2023
Registered

Trademark Image

ACCURACY IS NOT OPTIONAL

Basic Information

Serial Number
97442210
Filing Date
June 3, 2022
Published for Opposition
April 25, 2023
Drawing Code
4

Status Summary

Current Status
Active
Status Code
794
Status Date
Mar 9, 2024
Application
Pending
Classes
044

Rights Holder

Focalyx, LLC

16
Address
Suite 204
2140 West 68th Street
Miami Lakes, FL 33016

Ownership History

Focalyx, LLC

Original Applicant
16
Miami Lakes, FL

Focalyx, LLC

Owner at Publication
16
Miami Lakes, FL

Legal Representation

Attorney
Paul D. Bianco

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

11 events
Date Code Type Description Documents
Apr 11, 2025 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Feb 14, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Mar 9, 2024 JURT T JURISDICTION RESTORED TO EXAMINING ATTORNEY Loading...
Apr 25, 2023 ISMR Z WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST Loading...
Apr 25, 2023 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 25, 2023 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 5, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 20, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 20, 2023 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 7, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 7, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 044
Health care services, namely, management of Benning Prostate Hyperplasia, image-guided management of Benning Prostate Hyperplasia, image-guided treatment of Benning Prostate Hyperplasia, image-guided treatment of prostate diseases, image-guided management of prostate diseases; and healthcare services featuring focal management of cancer, target management of cancer, image-guided cancer diagnostics, image-guided focal cancer treatment, and focal cancer management with organ preservation
First Use Anywhere: May 13, 2022
First Use in Commerce: May 13, 2022

Classification

International Classes
044